Key facts
- Notable investors include European Innovation Council.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Ipremom
- ·The full record, as it builds
Funding rounds
No funding rounds for Ipremom are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ipremom
Developer of molecular diagnostic tests intended for the early detection of gestational diseases such as preeclampsia. The company is currently operating in Stealth mode.
- Sector
- Business Products and Services (B2B)
- HQ
- Valencia, Spain
- Founded
- 2019
- Employees
- 14
- Website
- ipremom.com/
- Ownership
- Privately Held (backing)
Ipremom doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ipremom shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ipremom in its N-PORT filings yet. We sweep new filings monthly.